爱德华生命科学 EW 深 沪
已收盘 12-05 16:00:00 美东时间
86.19
+0.410
+0.48%
华盛通- 最 高87.89
- 今 开86.31
- 成交量 346.13万股
- 最 低 85.945
- 昨 收 85.78
- 总市值 505.94亿
- 52周最高 87.89
- 市盈率 静 59.06
- 换手率 0.59%
- 52周最低 65.94
- 委 比 -55.75%
- 总股本 5.87亿
- 历史最高 131.73
- 量 比 1.31
- 振 幅 2.27%
- 历史最低 10.1033
- 每 手 1
- 风险率 4.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Edwards Lifesciences 2026 EPS guidance range includes consensus
Edwards Lifesciences (EW) newly projected 2026 adjusted EPS guidance of $2.80-$2.95 includes to consensus figure of $2.86. The maker of products to treat advanced cardiovascular diseases also sees con...
12-04 23:07
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
Study results show PEDMARK® significantly reduced cisplatin-induced hearing loss in pediatric patients, with rates of 16% and 24% compared to 56–63% in historical controls. The treatment had no adverse effect on tumor response, with a 95% clinical response rate, and Fennec Pharmaceuticals plans to pursue registration in Japan and explore partnership opportunities.
12-02 12:01
Japan yield spike is hitting the risk-on trade premarket
A sharp jump in Japanese government bond yields to the highest levels since 2008 is rippling through global markets Monday, stoking carry-trade concerns and weighing on risk assets. JGBs sold off afte...
12-01 18:17
电话会总结 ｜ Edwards Lifesciences (EW) Earnings Transcript
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Edwards Lifesciences (EW) 2025年第三季度业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 总销售额：15.5亿美元，同比增长12.6% - TAVR业务：11.5亿美元，同比增长10.6% - TMTT业务：1.44亿美元，同比增长53% - 外科业务：2.58亿美元，同比增长5.6% **盈利能力：** - 调整后每股收益(EPS)：0.67美元，超出预期 - GAAP每股收益：0.50美元 - 调整后毛利率：77.9%，低于去年同期的80.7% - 调整后营业利润率：27.5%
12-01 12:07
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
11-26 10:07
BTIG Reiterates Buy on Edwards Lifesciences, Maintains $100 Price Target
BTIG analyst Marie Thibault reiterates Edwards Lifesciences (NYSE:EW) with a Buy and maintains $100 price target.
11-25 19:05
法兴银行预警：AI狂热将迎来大清算，结局或比2008年更惨烈！
2008危机预言家再次出手！ 资深“大空头”警告：AI泡沫将是比次贷危机更惨烈的经济熔毁，美国富豪正在玩一场“火中取栗”的游戏。
11-24 22:10
Stock Market Bubble Worse Than 2008 Financial Crisis Is Brewing, Warns Analyst: 'People Just Don't Want To Listen Because...'
Albert Edwards, the Global Strategist at Société Générale, has raised a red flag on the current state of the U.S. equity market. He believes that the market, largely driven by tech and AI, is in the throes of a dangerous bubble that could have dire consequences.
11-24 18:05
美股大跌其实是因为日本？法兴银行：日债收益率飙升是最大风险信号
自称“超级看跌者”的法兴银行策略师Albert Edwards表示，担心美股牛市能否持续的投资者应关注日本债券收益率。
11-21 15:21
高市早苗将是“特拉斯2.0”？德银：日本资本外逃或重演昔日英国危机！
①德意志银行全球货币研究主管George Saravelos指出，高市早苗的支出计划已导致日本国债和日元汇率暴跌，引发了人们对无序资本外逃的担忧； ②这正让人联想起2022年那场几乎摧毁英国债券市场的动荡。
11-21 10:07
